Background: Many a long time of analysis demonstrates that the presence of and perceived high quality of the parent-child bond can impression a toddler’s well being, psychological well being, and interpersonal trajectory for a lifetime (Weinfield, Sroufe, Egeland, & Carlson, 1999 Handbook of attachment: Idea, analysis, and medical functions.
Doxorubicin hydrochloride
New York: Guilford Press, 68; Lieberman, Toddler Psychological Well being Journal, 25, 336, 2004). Nevertheless, investigations relating to the utility of strategies to guage the standard and nature of caregiver-child interactions are restricted. Utilizing medical information from 151 caregiver-child dyads, this examine examines the psychometric properties of the Crowell Downside Fixing Process Score Scale utilizing exploratory issue evaluation. Moreover, the predictive validity of the coding system was examined by way of comparisons with the Guardian-Toddler Relationship International Evaluation Scale (PIRGAS).
Findings: The kid and grownup scales had been every psychometrically outlined by a single issue that was internally constant and well-defined conceptually by the consultant gadgets. Excessive inner consistency for every scale supplies help for the reliability of the ranking scale, and means that the Crowell scores might be helpful as two separate scales measuring a toddler’s affective presentation and caregiver responsiveness, but additionally collectively as a complete rating assessing general relational functioning. Facets of the caregiver-child relationship had been considerably associated to PIRGAS scores on the kid and grownup domains.
Conclusions: The outcomes of this examine recommend the Crowell Downside Fixing Process Score Scale is a quick instrument, with good inner consistency, that may assess a variety of younger youngsters, in a medical setting.
Key phrases: Attachment; caregiver; youngster improvement; relationships.
Rising Prevalence of Multidrug-Resistant Candida haemulonii Species Advanced amongst All Yeast Cultures Collected by a Reference Laboratory over the Previous 11 Years
- There may be worldwide concern with the growing charges of infections attributable to multiresistant Candida isolates reported in tertiary medical facilities. We checked for historic traits when it comes to prevalence charges and antifungal susceptibility of the Candida haemulonii species complicated in our yeast inventory tradition collected over the last 11 years.
- The isolates had been recognized by sequencing the rDNA inner transcribed spacer (ITS) area, and antifungal susceptibility checks for amphotericin B, voriconazole, fluconazole, anidulafungin, and 5-fluorocytosine had been carried out by the Medical and Laboratory Requirements Institute (CLSI) microbroth methodology. A complete of 49 isolates had been recognized as Candida haemulonii sensu stricto (n = 21), adopted by C.
- haemulonii var. vulnera (n = 15) and C. duobushaemulonii (n = 13), together with 38 isolates cultured from sufferers with deep-seated Candida infections. The prevalence of the C.
 Doxorubicin hydrochloride USP |
|
D005-10MG |
TOKU-E |
10 mg |
EUR 166 |
Doxorubicin hydrochloride USP |
|
D005-25MG |
TOKU-E |
25 mg |
EUR 301 |
) Doxorubicin Hydrochloride (Autophagy inducer) |
|
SIH-390-10MG |
Stressmarq |
10 mg |
EUR 193 |
|
|
|
Description: The substance Doxorubicin Hydrochloride is a autophagy inducer. It is synthetically produced and has a purity of >98%. The pure substance is red solid which is soluble in water (50 mM).. |
Doxorubicin Hydrochloride (Autophagy inducer) |
|
SIH-390-50MG |
Stressmarq |
50 mg |
EUR 529 |
|
|
|
Description: The substance Doxorubicin Hydrochloride is a autophagy inducer. It is synthetically produced and has a purity of >98%. The pure substance is red solid which is soluble in water (50 mM).. |
 Erlotinib, Hydrochloride Salt |
|
1588-100 |
Biovision |
|
EUR 169 |
Erlotinib, Hydrochloride Salt |
|
1588-1000 |
Biovision |
|
EUR 398 |
 Doxorubicin |
|
D063-100MG |
TOKU-E |
100 mg |
EUR 1051 |
Doxorubicin |
|
D063-25MG |
TOKU-E |
25 mg |
EUR 322 |
Doxorubicin |
|
abx188695-1g |
Abbexa |
1 g |
EUR 467 |
|
|
Doxorubicin |
|
A3966-10 |
ApexBio |
10 mg |
EUR 108 |
|
Description: Doxorubicin is a semi-synthesized anticancer agent derived from bacterial culture. [1] It is an anthracycline antibiotic. It is been widely used in blood cancers, solid tumors and sarcomas. |
Doxorubicin |
|
A3966-100 |
ApexBio |
100 mg |
EUR 235 |
|
Description: Doxorubicin is a semi-synthesized anticancer agent derived from bacterial culture. [1] It is an anthracycline antibiotic. It is been widely used in blood cancers, solid tumors and sarcomas. |
Doxorubicin |
|
A3966-25 |
ApexBio |
25 mg |
EUR 131 |
|
Description: Doxorubicin is a semi-synthesized anticancer agent derived from bacterial culture. [1] It is an anthracycline antibiotic. It is been widely used in blood cancers, solid tumors and sarcomas. |
Doxorubicin |
|
A3966-5.1 |
ApexBio |
10 mM (in 1mL DMSO) |
EUR 131 |
|
Description: Doxorubicin is a semi-synthesized anticancer agent derived from bacterial culture. [1] It is an anthracycline antibiotic. It is been widely used in blood cancers, solid tumors and sarcomas. |
Doxorubicin |
|
A3966-S |
ApexBio |
Evaluation Sample |
EUR 81 |
|
Description: Doxorubicin is a semi-synthesized anticancer agent derived from bacterial culture. [1] It is an anthracycline antibiotic. It is been widely used in blood cancers, solid tumors and sarcomas. |
 Erlotinib, Hydrochloride Salt, >99% |
|
BC026-101 |
GenDepot |
1g |
EUR 273 |
Erlotinib, Hydrochloride Salt, >99% |
|
BC026-102 |
GenDepot |
2g |
EUR 388 |
Erlotinib, Hydrochloride Salt, >99% |
|
BC026-105 |
GenDepot |
5g |
EUR 570 |
) Adriamycin (Doxorubicin) |
|
E1KS1208 |
EnoGene |
10mg |
EUR 409 |
 Doxorubicin HCl |
|
20-abx184016 |
Abbexa |
|
|
|
|
 Doxorubicin 10mM |
|
TG4120 |
TopoGen |
0.25ml |
EUR 156 |
 17-DMAG, Hydrochloride Salt, >98% |
|
BC024-001 |
GenDepot |
1mg |
EUR 178 |
17-DMAG, Hydrochloride Salt, >98% |
|
BC024-005 |
GenDepot |
5mg |
EUR 286 |
17-DMAG, Hydrochloride Salt, >98% |
|
BC024-010 |
GenDepot |
10mg |
EUR 408 |
17-DMAG, Hydrochloride Salt, >98% |
|
BC024-025 |
GenDepot |
25mg |
Ask for price |
 17-DMAG, Hydrochloride Salt, >99% |
|
BC024-100 |
GenDepot |
100mg |
Ask for price |
17-DMAG, Hydrochloride Salt, >99% |
|
BC024-101 |
GenDepot |
1g |
Ask for price |
17-DMAG, Hydrochloride Salt, >99% |
|
BC024-250 |
GenDepot |
250mg |
Ask for price |
 OSU-03012, Hydrochloride Salt, >98% |
|
BC061-005 |
GenDepot |
5mg |
EUR 313 |
OSU-03012, Hydrochloride Salt, >98% |
|
BC061-025 |
GenDepot |
25mg |
EUR 529 |
 Doxorubicin HCl, 100mg |
|
R2531-100mg |
ACTGene |
|
EUR 1300 |
 Doxorubicin HCl, 10mg |
|
R2531-10mg |
ACTGene |
|
EUR 197 |
 HCl) Doxorubicin (Adriamycin) HCl |
|
A1832-10 |
ApexBio |
10 mg |
EUR 125 |
|
Description: Doxorubicin is a semi-synthesized anticancer agent derived from bacterial culture. [1] It is an anthracycline antibiotic. It is been widely used in blood cancers, solid tumors and sarcomas. |
Doxorubicin (Adriamycin) HCl |
|
A1832-100 |
ApexBio |
100 mg |
EUR 467 |
|
Description: Doxorubicin is a semi-synthesized anticancer agent derived from bacterial culture. [1] It is an anthracycline antibiotic. It is been widely used in blood cancers, solid tumors and sarcomas. |
Doxorubicin (Adriamycin) HCl |
|
A1832-25 |
ApexBio |
25 mg |
EUR 189 |
|
Description: Doxorubicin is a semi-synthesized anticancer agent derived from bacterial culture. [1] It is an anthracycline antibiotic. It is been widely used in blood cancers, solid tumors and sarcomas. |
Doxorubicin (Adriamycin) HCl |
|
A1832-5.1 |
ApexBio |
10 mM (in 1mL DMSO) |
EUR 113 |
|
Description: Doxorubicin is a semi-synthesized anticancer agent derived from bacterial culture. [1] It is an anthracycline antibiotic. It is been widely used in blood cancers, solid tumors and sarcomas. |
 Anti-EGFR-doxorubicin ADC |
|
ADC-W-600 |
Creative Biolabs |
1mg |
Ask for price |
|
Description: This ADC product is comprised of an anti-EGFR monoclonal antibody conjugated via a linker to a doxorubicin |
 Anti-CD22-DIBO-doxorubicin ADC |
|
ADC-W-339 |
Creative Biolabs |
1mg |
Ask for price |
|
Description: This ADC product is comprised of an anti-CD22 monoclonal antibody conjugated via a DIBO linker to a doxorubicin |
-DIBO-doxorubicin ADC) Anti-TNFRSF8 (cAC10)-DIBO-doxorubicin ADC |
|
ADC-W-406 |
Creative Biolabs |
1mg |
Ask for price |
|
Description: This ADC product is comprised of an anti-TNFRSF8 monoclonal antibody (cAC10) conjugated via a DIBO linker to a doxorubicin |
-NGM-doxorubicin ADC) Anti-ERBB2 (Trastuzumab)-NGM-doxorubicin ADC |
|
ADC-W-412 |
Creative Biolabs |
1mg |
Ask for price |
|
Description: This ADC product is comprised of an anti-ERBB2 monoclonal antibody conjugated via a NGM linker to adoxorubicin |
-SMCC-Doxorubicin ADC) Anti-EGFR (cetuximab)-SMCC-Doxorubicin ADC |
|
ADC-W-504 |
Creative Biolabs |
1mg |
Ask for price |
|
Description: This ADC product is comprised of an anti-EGFR monoclonal antibody (cetuximab) conjugated via a SMCC linker to Doxorubicin |
-hydrazone-Doxorubicin ADC) Anti-EpCAM (MOC31)-hydrazone-Doxorubicin ADC |
|
ADC-W-581 |
Creative Biolabs |
1mg |
Ask for price |
|
Description: This ADC product is comprised of an anti-EPCAM monoclonal antibody (MOC31) conjugated via a hydrazone linker to Doxorubicin |
-hydrazone-doxorubicin ADC) Anti-FUT3 (clone cBR96)-hydrazone-doxorubicin ADC |
|
ADC-W-423 |
Creative Biolabs |
1mg |
Ask for price |
|
Description: This ADC product is comprised of an anti-FUT3 monoclonal antibody (clone cBR96) conjugated via a hydrazone linker to adoxorubicin |
-β-glucuronide-doxorubicin ADC) Anti-CD70 (clone h1F6)-β-glucuronide-doxorubicin ADC |
|
ADC-W-376 |
Creative Biolabs |
1mg |
Ask for price |
|
Description: This ADC product is comprised of an anti-CD70 monoclonal antibody (clone h1F6) conjugated via a β-glucuronide linker to a doxorubicin |
-β-glucuronide-doxorubicin propyloxazoline (DPO) ADC) Anti-TNFRSF8 (cCA10)-β-glucuronide-doxorubicin propyloxazoline (DPO) ADC |
|
ADC-W-353 |
Creative Biolabs |
1mg |
Ask for price |
|
Description: This ADC product is comprised of an anti-TNFRSF8 monoclonal antibody (cCA10) conjugated via a β-glucuronide linker to a doxorubicin propyloxazoline (DPO) |
 Cell Nuclear Extract - Doxorubicin Stimulated) Human HeLa (Cervix Adenocarcinoma) Cell Nuclear Extract - Doxorubicin Stimulated |
|
HCL-2004 |
Alpha Diagnostics |
100ug |
EUR 225 |
 Whole Cell Lysate - Doxorubicin Stimulated) Human HeLa (Cervix Adenocarcinoma) Whole Cell Lysate - Doxorubicin Stimulated |
|
HCL-2010 |
Alpha Diagnostics |
100ug |
EUR 213 |
 THZ1 hydrochloride |
|
9544-25 |
Biovision |
|
EUR 1023 |
 Bestatin hydrochloride |
|
9630-25 |
Biovision |
|
EUR 457 |
Bestatin hydrochloride |
|
9630-5 |
Biovision |
|
EUR 153 |
 Ambroxol hydrochloride |
|
9688-100 |
Biovision |
|
EUR 142 |
Ambroxol hydrochloride |
|
9688-500 |
Biovision |
|
EUR 262 |
 Tetracycline, Hydrochloride |
|
CH054 |
ABM |
25 g |
EUR 119 |
Tetracycline, Hydrochloride |
|
CH055 |
ABM |
100 g |
EUR 170 |
 Palmatine hydrochloride |
|
TB0031 |
ChemNorm |
10X20mg |
EUR 274 |
 Triacetonamine hydrochloride |
|
TB01047 |
ChemNorm |
unit |
Ask for price |
 Berberine hydrochloride |
|
TB0119-1000 |
ChemNorm |
8XX20mg |
EUR 274 |
 Betaine hydrochloride |
|
TB0136 |
ChemNorm |
8XX20mg |
EUR 274 |
 Sinomenine Hydrochloride |
|
TB0150 |
ChemNorm |
6X20mg |
EUR 257 |
 Ligustrazine Hydrochloride |
|
TB0189 |
ChemNorm |
10X20mg |
EUR 274 |
 Jatrorrhizine Hydrochloride |
|
TB0285 |
ChemNorm |
3X20mg |
EUR 291 |
 Leonurine Hydrochloride |
|
TB0408-0020 |
ChemNorm |
20mg |
EUR 228 |
 Leonurine hydrochloride |
|
TB0539 |
ChemNorm |
3X20mg |
EUR 291 |
 Berbamine hydrochloride |
|
TB0619 |
ChemNorm |
8XX20mg |
EUR 274 |
 Harmine hydrochloride |
|
TB0656 |
ChemNorm |
5X20mg |
EUR 274 |
 Trigonelline hydrochloride |
|
TB0720-0500 |
ChemNorm |
8XX20mg |
EUR 274 |
 Tomatidine hydrochloride |
|
TB0825-0025 |
ChemNorm |
20mg |
EUR 291 |
 Norglaucine hydrochloride |
|
TBP03165 |
ChemNorm |
5mg |
EUR 1144 |
 Dehydroevodiamine hydrochloride |
|
TBP03315 |
ChemNorm |
unit |
Ask for price |
- haemulonii species complicated elevated from 0.9% (18 isolates amongst 1931) within the first interval (December 2008 to June 2013) to 1.7% (31 isolates amongst 1868) within the second interval (July 2014 to December 2019) of research (p = 0.047).
- All isolates examined exhibited excessive minimal inhibition concentrations for amphotericin B and fluconazole, however they remained inclined to 5-fluorocytosine and anidulafungin. We had been capable of display the elevated isolation of the multiresistant Candida haemulonii species complicated in our tradition assortment, the place most isolates had been cultured from sufferers with deep-seated infections.
Key phrases: Candida haemulonii species complicated; antifungal resistance; candidemia; cryptic Candida species; nosocomial fungal infections.
Erlotinib, Hydrochloride Salt
We report on a thermally steady monolithic Doppler uneven spatial heterodyne (DASH) interferometer with field-widening prisms for thermospheric wind measurements by observing the Doppler shift of the airglow emission.
 gel casting base for evs3100 |
|
EVS3100-BASE |
Consort |
ea |
EUR 301 |
 gel casting base for evs3200 |
|
EVS3200-BASE |
Consort |
ea |
EUR 301 |
 gel casting base for evs3300 |
|
EVS3300-BASE |
Consort |
ea |
EUR 301 |
) PLX5622 (free base) |
|
B2965-25 |
Biovision |
25 mg |
EUR 753 |
PLX5622 (free base) |
|
B2965-5 |
Biovision |
5 mg |
EUR 227 |
 Vatalanib, Free Base |
|
2026-25 |
Biovision |
|
EUR 305 |
Vatalanib, Free Base |
|
2026-5 |
Biovision |
|
EUR 126 |
 Erlotinib, Free Base |
|
2048-100 |
Biovision |
|
EUR 158 |
Erlotinib, Free Base |
|
2048-1000 |
Biovision |
|
EUR 387 |
 Linsitinib, Free base |
|
2294-25 |
Biovision |
|
EUR 566 |
Linsitinib, Free base |
|
2294-5 |
Biovision |
|
EUR 185 |
 Tipifarnib, Free base |
|
2296-1 |
Biovision |
|
EUR 142 |
Tipifarnib, Free base |
|
2296-5 |
Biovision |
|
EUR 414 |
 Sunitinib, Free base |
|
2097-100 |
Biovision |
|
EUR 191 |
Sunitinib, Free base |
|
2097-1000 |
Biovision |
|
EUR 501 |
Sunitinib, Free base |
|
2097-25 |
Biovision |
|
EUR 115 |
 Lapatinib, Free base |
|
2138-100 |
Biovision |
|
EUR 387 |
Lapatinib, Free base |
|
2138-25 |
Biovision |
|
EUR 191 |
 Ruxolitinib, Free base |
|
2139-100 |
Biovision |
|
Ask for price |
Ruxolitinib, Free base |
|
2139-25 |
Biovision |
|
EUR 533 |
Ruxolitinib, Free base |
|
2139-5 |
Biovision |
|
EUR 207 |
 Imatinib, Free base |
|
2141-100 |
Biovision |
|
EUR 147 |
Imatinib, Free base |
|
2141-1000 |
Biovision |
|
EUR 419 |
) Apatinib (Free base) |
|
B1613-25 |
Biovision |
|
EUR 414 |
Apatinib (Free base) |
|
B1613-5 |
Biovision |
|
EUR 142 |
) Carubicin (Free base) |
|
B1853-1 |
Biovision |
|
EUR 153 |
Carubicin (Free base) |
|
B1853-5 |
Biovision |
|
EUR 457 |
) Terbinafine (Free base) |
|
B2423-250 |
Biovision |
|
EUR 207 |
Terbinafine (Free base) |
|
B2423-50 |
Biovision |
|
EUR 120 |
) R406(free base) |
|
E1KS1533 |
EnoGene |
2mg |
EUR 521 |
 LY2835219 free base |
|
A3575-100 |
ApexBio |
100 mg |
EUR 572 |
|
Description: LY2835219 is an orally available cyclin-dependent kinase (CDK) inhibitor that targets the CDK4 (cyclin D1) and CDK6 (cyclin D3) cell cycle pathway, with potential antineoplastic activity. |
LY2835219 free base |
|
A3575-25 |
ApexBio |
25 mg |
EUR 258 |
|
Description: LY2835219 is an orally available cyclin-dependent kinase (CDK) inhibitor that targets the CDK4 (cyclin D1) and CDK6 (cyclin D3) cell cycle pathway, with potential antineoplastic activity. |
LY2835219 free base |
|
A3575-5 |
ApexBio |
5 mg |
EUR 142 |
|
Description: LY2835219 is an orally available cyclin-dependent kinase (CDK) inhibitor that targets the CDK4 (cyclin D1) and CDK6 (cyclin D3) cell cycle pathway, with potential antineoplastic activity. |
) R406 (free base) |
|
A5880-100 |
ApexBio |
100 mg |
EUR 1210 |
|
Description: R406 is a potent SYK inhibitorSpleen tyrosine kinase (SYK) is a non-receptor tyrosine kinase mainly expressed in hematopoietic cells. It transmits signals from a variety of cell surface receptors including CD74, Fc receptor and integrins. |
R406 (free base) |
|
A5880-25 |
ApexBio |
25 mg |
EUR 514 |
|
Description: R406 is a potent SYK inhibitorSpleen tyrosine kinase (SYK) is a non-receptor tyrosine kinase mainly expressed in hematopoietic cells. It transmits signals from a variety of cell surface receptors including CD74, Fc receptor and integrins. |
R406 (free base) |
|
A5880-5 |
ApexBio |
5 mg |
EUR 166 |
|
Description: R406 is a potent SYK inhibitorSpleen tyrosine kinase (SYK) is a non-receptor tyrosine kinase mainly expressed in hematopoietic cells. It transmits signals from a variety of cell surface receptors including CD74, Fc receptor and integrins. |
R406 (free base) |
|
A5880-5.1 |
ApexBio |
10 mM (in 1mL DMSO) |
EUR 264 |
|
Description: R406 is a potent SYK inhibitorSpleen tyrosine kinase (SYK) is a non-receptor tyrosine kinase mainly expressed in hematopoietic cells. It transmits signals from a variety of cell surface receptors including CD74, Fc receptor and integrins. |
R406 (free base) |
|
A5880-S |
ApexBio |
Evaluation Sample |
EUR 81 |
|
Description: R406 is a potent SYK inhibitorSpleen tyrosine kinase (SYK) is a non-receptor tyrosine kinase mainly expressed in hematopoietic cells. It transmits signals from a variety of cell surface receptors including CD74, Fc receptor and integrins. |
) Rucaparib (free base) |
|
A8893-10 |
ApexBio |
10 mg |
EUR 200 |
|
Description: Rucaparib, also named as AG-014699 or PF-01367338, is a poly (ADP ribose) polymerase (PARP) inhibitor. PARP is a DNA damage-activated nuclear enzyme that has a key signaling role in the base excision repair pathway. |
Rucaparib (free base) |
|
A8893-200 |
ApexBio |
200 mg |
EUR 1036 |
|
Description: Rucaparib, also named as AG-014699 or PF-01367338, is a poly (ADP ribose) polymerase (PARP) inhibitor. PARP is a DNA damage-activated nuclear enzyme that has a key signaling role in the base excision repair pathway. |
Rucaparib (free base) |
|
A8893-5 |
ApexBio |
5 mg |
EUR 137 |
|
Description: Rucaparib, also named as AG-014699 or PF-01367338, is a poly (ADP ribose) polymerase (PARP) inhibitor. PARP is a DNA damage-activated nuclear enzyme that has a key signaling role in the base excision repair pathway. |
Rucaparib (free base) |
|
A8893-5.1 |
ApexBio |
10 mM (in 1mL DMSO) |
EUR 142 |
|
Description: Rucaparib, also named as AG-014699 or PF-01367338, is a poly (ADP ribose) polymerase (PARP) inhibitor. PARP is a DNA damage-activated nuclear enzyme that has a key signaling role in the base excision repair pathway. |
Rucaparib (free base) |
|
A8893-50 |
ApexBio |
50 mg |
EUR 456 |
|
Description: Rucaparib, also named as AG-014699 or PF-01367338, is a poly (ADP ribose) polymerase (PARP) inhibitor. PARP is a DNA damage-activated nuclear enzyme that has a key signaling role in the base excision repair pathway. |
) Xylazine (free base) |
|
Q-1445.0025 |
Bachem |
25.0g |
EUR 321 |
|
Description: Sum Formula: C12H16N2S; CAS# [7361-61-7] |
 RGB-286638, free base |
|
2886-25 |
Biovision |
|
EUR 756 |
RGB-286638, free base |
|
2886-5 |
Biovision |
|
EUR 229 |
 StemRegenin 1, Free base |
|
2642-1 |
Biovision |
|
EUR 131 |
StemRegenin 1, Free base |
|
2642-5 |
Biovision |
|
EUR 332 |
) BMS-345541 (Free base) |
|
B1907-1 |
Biovision |
|
EUR 142 |
BMS-345541 (Free base) |
|
B1907-5 |
Biovision |
|
EUR 414 |
 UNC-926, free base |
|
B2158-25 |
Biovision |
|
EUR 631 |
Analytical deduction and numerical simulation are utilized to find out the central optical path distinction, the thermal compensation situation and the field-widening design. A monolithic interferometer with optimized configuration was constructed and examined within the laboratory.
Laboratory checks present that the very best visibility of 0.94 was realized with the 9 ° field-of-view illumination, whereas the thermal responses of the spatial frequency and the optical section offset are 0.0154 cm-1/°C and 0.469 rad/°C, respectively.
)
)
)
)
)
)
)
)
)
)